Literature DB >> 2523641

Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood.

J A Panza1, B J Maron.   

Abstract

Patients with hypertrophic cardiomyopathy (HC) often show substantial increases in left ventricular (LV) wall thickness or even de novo development of LV hypertrophy during childhood. To determine the utility of the electrocardiogram in reflecting such changes in LV mass, serial 12-lead electrocardiograms and 2-dimensional echocardiograms were analyzed in 38 children with HC. The period of evaluation ranged from 3 to 8 years (mean 5.5). Between the initial and most recent clinical evaluations, precordial and standard lead voltages did not change significantly in the study patients, including those showing evolution of LV hypertrophy by 2-dimensional echocardiography; furthermore, only 9 of the 38 patients (23%) showed any substantial change in the overall electrocardiographic pattern. However, the magnitude of electrocardiographic voltages at initial evaluation (age 11 +/- 4 years) showed a significant correlation with the extent of LV hypertrophy at the most recent evaluation as assessed by echocardiography (at age 16 +/- 4 years) (r = 0.65, p less than 0.001). Of note, each of the 7 patients who developed LV hypertrophy during the period of observation had distinct electrocardiographic abnormalities at the initial evaluation that preceded the appearance of LV hypertrophy on the echocardiogram. In conclusion, in children with HC and evolving LV hypertrophy, the electrocardiogram showed little change during the period of observation. However, electrocardiographic abnormalities may be the initial manifestation of HC, appearing even before LV hypertrophy is detectable by echocardiography. Hence, in patients with HC the electrocardiogram may provide advance evidence of morphologic changes that will subsequently occur and may describe the magnitude of LV hypertrophy ultimately achieved an average of 5 years later.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2523641     DOI: 10.1016/0002-9149(89)90187-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited.

Authors:  B J Maron
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

2.  Detection of repolarization abnormalities in patients with cardiomyopathy using current vector mapping technique on magnetocardiogram.

Authors:  Junko Shiono; Hitoshi Horigome; Akira Matsui; Yasushi Terada; Tsuyoshi Miyashita; Keiji Tsukada
Journal:  Int J Cardiovasc Imaging       Date:  2003-04       Impact factor: 2.357

3.  Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase.

Authors:  Polina Sysa-Shah; Lars L Sørensen; M Roselle Abraham; Kathleen L Gabrielson
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

4.  Validity of electrocardiographic criteria for left ventricular hypertrophy in children with pressure- or volume-loaded ventricles: comparison with echocardiographic left ventricular muscle mass.

Authors:  M A Fogel; D R Lieb; M A Seliem
Journal:  Pediatr Cardiol       Date:  1995 Nov-Dec       Impact factor: 1.655

5.  Usefulness of the pediatric electrocardiogram in detecting left ventricular hypertrophy: results from the Prospective Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) multicenter study.

Authors:  Shannon M Rivenes; Steven D Colan; Kirk A Easley; Samuel Kaplan; Kathy J Jenkins; Mohammed N Khan; Wyman W Lai; Steven E Lipshultz; Douglas S Moodie; Thomas J Starc; George Sopko; Weihong Zhang; J Timothy Bricker
Journal:  Am Heart J       Date:  2003-04       Impact factor: 4.749

6.  Identification of a mutation in the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy.

Authors:  S al-Mahdawi; S Chamberlain; J Cleland; P Nihoyannopoulos; D Gilligan; J French; L Choudhury; R Williamson; C Oakley
Journal:  Br Heart J       Date:  1993-02

Review 7.  Athlete's heart electrocardiogram mimicking hypertrophic cardiomyopathy.

Authors:  A Pelliccia; B J Maron
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

8.  Electrocardiographic criteria for left ventricular hypertrophy in children.

Authors:  Peter R Rijnbeek; Gerard van Herpen; Livia Kapusta; A Derk Jan Ten Harkel; Maarten Witsenburg; Jan A Kors
Journal:  Pediatr Cardiol       Date:  2008-04-25       Impact factor: 1.655

9.  The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene.

Authors:  S al-Mahdawi; S Chamberlain; L Chojnowska; E Michalak; P Nihoyannopoulos; M Ryan; B Kusnierczyk; J A French; D M Gilligan; J Cleland
Journal:  Br Heart J       Date:  1994-08

10.  Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.

Authors:  B M Posen; J C Moolman; V A Corfield; P A Brink
Journal:  Br Heart J       Date:  1995-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.